2. Tortorello M. Is It Safe to Play Yet? // New York Times, March 14, 2012 // http://www.nytimes.com/2012/03/15/garden/going-to-extreme-lengths-to-purge-household-toxins.html.
3. Campbell C., Friedman L. Chemical Assay and Isolation of Chick Edema Factor in Biological Materials // Journal of the American Association for Agricultural Chemistry, 1966. Vol. 49. P. 824–828. Я столкнулся с ним задолго до перехода на ЦРД в 1980-х годах.
4. Huff J., Jacobson M. F., Davis D. L. The Limits of Two-Year Bioassay Exposure Regimens for Identifying Chemical Carcinogens // Environmental Health Perspectives, 2008. Vol. 116. P. 1439–1442.
5. Cohen S. M. Risk Assessment in the Genomic Era // Toxicologic Pathology, 2004. Vol. 32. P. 3–8.
Глава 10
1. Singh Y., Palombo M., Sinko P. J. Recent Trends in Targeted Anticancer Prodrug and Conjugate Design // Current Medicinal Chemistry, 2008. Vol. 15, N. 18. P. 1802–1826; Lu Y. H., Gao X. Q., Wu M. et al. Strategies on the Development of Small Molecule Anticancer Drugs for Targeted Therapy // Mini Reviews in Medicinal Chemistry, 2011. Vol. 11. P. 611–624; Munagala R., Aqil F., Gupta R. C., Promising Molecular Targeted Therapies in Breast Cancer // Indian Journal of Pharmacology, 2011. Vol. 43, N. 3. P. 236–245; Panitch H., Applebee A. Treatment of Walking Impairment in Multiple Sclerosis: An Unmet Need for a Disease-Specific Disability // Expert Opinion on Pharmacotherapy, 2011, March 12. N. 10. P. 1511–1521; Rautio J., Kumpulainen H., Heimbach T. et al. Prodrugs: Design and Clinical Applications // Nature Reviews: Drug Discovery, 2008. Vol. 7, N. 3. P. 255–270; Ettmayer P., Amidon G. L., Clement B., Testa B. Lessons Learned from Marketed and Investigational Prodrugs // Journal of Medicinal Chemistry, 2004, May. Vol. 47, N. 10. P. 2393–2404.
2. Из-за этого фармацевтические компании заинтересованы в сохранении тропических лесов как источника лекарственных средств. Но это, возможно, единственный положительный побочный эффект.
3. Singh et al. Recent Trends.
4. Internationals Statistical Classification of Diseases and Related Health Problems // Answers.com. По состоянию на 11 ноября 2012 года // http://www.answers.com/topic/icd.
Глава 11
1. Thurston C. Dietary Supplements: The Latest Trends & Issues // Neutraceuticals World, 2008, April 1 // http://www.nutraceuticalsworld.com/issues/2008-04/view_features/dietary-supplements-the-latest-trends-amp-issues/.
2. Thurston C. Dietary Supplements: The Latest Trends & Issues // Nutraceuticals World, 2008, April // http://www.nutraceuticalsworld.com/issues/2008-04/view_features/dietary-supplements-the-latest-trends-amp-issues.
3. Apples, Raw, Skin. Self NutritionData. По данным на 11 ноября 2012 года // http://nutritiondata.self.com/facts/fruits-and-fruit-juices/1809/2.
4. Eberhardt M. V., Lee C. Y., Liu R. H. Antioxidant Activity of Fresh Apples // Nature, 2000, June 22. Vol. 405, N. 6789. P. 903–904.
5. Boyer J., Liu R. H. Review: Apple Phytochemicals and Their Health Effects // Nutrition Journal, 2004. Vol. 3, N. 5 // http://www.nutritionj.com/content/3/1/5.
6. Boyer J., Liu R. H. Review: Apple Phytochemicals and Their Health Effects // Nutrition Journal, 2004. Vol. 3, N. 5 // http://www.nutritionj.com/content/3/1/5; Wolfe K., Wu X. Z., Liu R. H. Antioxidant Activity of Apple Peels // Journal of Agricultural and Food Chemistry, 2003, January 29. Vol. 51, N. 3. P. 609–614.
7. Morris C. D., Carson S. Routine Vitamin Supplementation to Prevent Cardiovascular Disease: A Summary of the Evidence for the U.S. Preventive Services Task Force // Annals of Internal Medicine, 2003. Vol. 139, N. 1. P. 56–70.
8. U.S. Preventive Services Task Force. Routine Vitamin Supplementation to Prevent Cancer and Cardiovascular Disease: Recommendations and Rationale // Annals of Internal Medicine, 2003. Vol. 139, N. 1. P. 51–55.
9. U.S. Preventive Services Task Force. Routine Vitamin Supplementation to Prevent Cancer and Cardiovascular Disease: Recommendations and Rationale // Annals of Internal Medicine, 2003. Vol. 139, N. 1. P. 51–55.
10. Evans H. M., Bishop K. S. On the Existence of a Hitherto Unrecognized Dietary Factor Essential for Reproduction // Science, 1922. Vol. 56, N. 1458. P. 650–651.
11. Farbstein D., Kozak-Blickstein A., Levy A. P. Antioxidant Vitamins and Their Use in Preventing Cardiovascular Disease // Molecules, 2010. Vol. 15, N. 11. P. 8098–8110; Aggarwal B. B., Sundarum C., Prasad S., Kannappan R. Tocotrienols, the Vitamin E of the 21st Century: Its Potential against Cancer and Other Chronic Diseases // Biochemical Pharmacology, 2010. Vol. 80, N. 11. P. 1613–1631.
12. Hennekens C. H., Gaziano J. M., Manson J. E., Buring J. E. Antioxidant Vitamin-Cardiovascular Disease Hypothesis Is Still Promising, But Still Unproven: The Need for Randomized Trials // American Journal of Clinical Nutrition, 1995. Vol. 62. P. 1377S–1380S.
13. Pearce B. C., Parker R. A., Deason M. E. et al. Hypercholesterolemic Activity of Synthetic and Natural Tocotrienols // Journal of Medicinal Chemistry, 1992. Vol. 35, N. 20. P. 3595–3606.
14. Pearce B. C., Parker R. A., Deason M. E. et al. Hypercholesterolemic Activity of Synthetic and Natural Tocotrienols // Journal of Medicinal Chemistry, 1992. Vol. 35, N. 20. P. 3595–3606.
15. Augustyniak A. et al. Natural and Synthetic Antioxidants: An Updated Overview // Free Radical Research, 2010. Vol. 44, N. 10. P. 1216–1262.
16. Rimm E. B., Stampfer M. J., Ascherio A. et al. Vitamin E Consumption and the Risk of Coronary Heart Disease in Men // New England Journal of Medicine, 1993, May 20. Vol. 328, N. 20. P. 1450–1456; Stampfer M. J., Hennekens C. H., Manson J. E. et al. Vitamin E Consumption and the Risk of Coronary Disease in Women // New England Journal of Medicine, 1993, May 20. Vol. 328, N. 20. P. 1444–1449.
17. Sesso et al. Vitamins E and C; Lee I. M., Cook N. R., Gaziano J. M. et al. Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer: The Women’s Health Study: A Randomized Controlled Trial // Journal of the American Medical Association, 2005. Vol. 294, N. 1. P. 56–65; Lonn E. et al. Effects of Long-Term Vitamin E Supplementation on Cardiovascular Events and Cancer: A Randomized Controlled Trial // Journal of the American Medical Association, 2005. Vol. 293, N. 11. P. 1338–1347; Vivekananthan D. P., Penn M. S., S. K. Sapp et al. Use of Antioxidant Vitamins for the Prevention of Cardiovascular Disease: Meta-analysis of Randomised Trials // Lancet, 2003, June 14. Vol. 361, No. 9374. P. 2017–2023.
18. Lee et al. Vitamin E in the Primary Prevention; Lonn et al. Effects of Long-Term Vitamin E; Kirsh V. A. et al. Supplemental and Dietary Vitamin E, Beta-Carotene, and Vitamin C Intakes and Prostate Cancer Risk // Journal of the National Cancer Institute, 2006, February 15. Vol. 98, N. 4. P. 245–254; Lippman S. M. et al. Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT) // Journal of the American Medical Association, 2009, January 7. Vol. 301, N. 1. P. 39–51.
19. Lippman et al. Effect of Selenium; Liu S., Lee I. M., Song Y. et al. Vitamin E and Risk of Type 2 Diabetes in the Women’s Health Study Randomized Controlled Trial // Diabetes, 2006, October. Vol. 55, N. 10. P. 2856–2862.
20. Christen W. G., Glynn R. J., Sesso H. D. et al. Age-Related Cataract in a Randomized Trial of Vitamins E and C in Men // Archives of Ophthalmology, 2010, November. Vol. 128, N. 11. P. 1397–1405.
21. Tsiligianni I. G., van der Molen T. A Systematic Review of the Role of Vitamin Insufficiencies and Supplementation in COPD // Respiratory Research, 2010, December 6. Vol. 11. P. 171.
22. Bjelakovic G., Nikolova D., Gluud L. L. et al. Antioxidant Supplements for Prevention of Mortality in Healthy Participants and Patients with Various Diseases // Cochrane Database of Systematic Reviews, 2012. Vol. 3.
23. Dotan Y., Lichtenberg D., Pinchuk I. No Evidence Supports Vitamin E Indiscriminate Supplementation // Biofactors, 2009. Vol. 35, N. 6. P. 469–473; Blumberg J., Frei B. Why Clinical Trials of Vitamin E and Cardiovascular Diseases May Be Fatally Flawed // Free Radical Biology & Medicine, 2007. Vol. 43, N. 10. P. 1374–1376.
24. Aggarwal et al. Tocotrienols.
25. Farbstein et al. Antioxidant Vitamins.
26. Lonn et al. Effects of Long-Term Vitamin E.
27. Bjelakovic et al. Mortality in Randomized Trials; Miller et al. Meta-analysis.
28. Ebbesson S. O. et al. Fatty Acid Consumption and Metabolic Syndrome Components: The GOCADAN Study // Journal of the Cardiometabolic Syndrome, 2007. Vol. 2, N. 4. P. 244–249.
29. Lopez-Garcia E., Schulze M. B., Manson J. E. et al. Consumption of (n-3) Fatty Acids Is Related to Plasma Biomarkers of Inflammation and Endothelial Activation in Women // Journal of Nutrition, 2004. Vol. 134, N. 7. P. 1806–1811; Deckelbaum R. J., Worgall T. S., Seo T. n-3 Fatty Acids and Gene Expression // Suppl., American Journal of Clinical Nutrition, 2006. Vol. 83, N. 6. P. 1520S–1525S.
30. Kaushik S. V., Mozaffarian D., Spiegelman D. et al. Long-Chain Omega-3 Fatty Acids, Fish Intake, and the Risk of Type 2 Diabetes Mellitus // American Journal of Clinical Nutrition, 2009. Vol. 90, N. 3. P. 613–620.
31. Hooper L. et al. Risks and Benefits of Omega 3 Fats for Mortality, Cardiovascular Disease, and Cancer: Systematic Review // BMJ, 2006. Vol. 332, N. 7544. P. 752–760.
32. Kaushik et al. Long-Chain Omega-3 Fatty Acids.
33. Foote C. S., Chang Y. C., Denny R. W. Chemistry of Singlet Oxygen. X. Carotenoid Quenching Parallels Biological Protection // Journal of the American Chemical Society, 1970. Vol. 92, N. 17. P. 5216–5218; Packer J. E., Mahood J. S., Mora-Arellano V. O. et al. Free Radicals and Singlet Oxygen Scavengers: Reactio